Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 09 04:00PM ET
116.43
Dollar change
+2.57
Percentage change
2.26
%
IndexS&P 500 P/E36.75 EPS (ttm)3.17 Insider Own0.72% Shs Outstand1.73B Perf Week2.79%
Market Cap202.58B Forward P/E22.64 EPS next Y5.14 Insider Trans-0.26% Shs Float1.73B Perf Month6.08%
Income5.54B PEG4.48 EPS next Q1.20 Inst Own79.79% Short Float0.73% Perf Quarter8.23%
Sales40.73B P/S4.97 EPS this Y4.96% Inst Trans0.27% Short Ratio2.03 Perf Half Y-3.75%
Book/sh22.60 P/B5.15 EPS next Y10.35% ROA7.56% Short Interest12.68M Perf Year15.66%
Cash/sh4.15 P/C28.06 EPS next 5Y8.20% ROE14.47% 52W Range89.67 - 121.64 Perf YTD5.78%
Dividend Est.2.23 (1.91%) P/FCF35.83 EPS past 5Y19.65% ROI10.55% 52W High-4.28% Beta0.71
Dividend TTM2.16 (1.86%) Quick Ratio1.18 Sales past 5Y6.10% Gross Margin50.63% 52W Low29.84% ATR (14)1.79
Dividend Ex-DateJul 15, 2024 Current Ratio1.68 EPS Y/Y TTM7.89% Oper. Margin16.24% RSI (14)70.34 Volatility1.62% 1.28%
Employees114000 Debt/Eq0.38 Sales Y/Y TTM1.24% Profit Margin13.59% Recom1.78 Target Price125.25
Option/ShortYes / Yes LT Debt/Eq0.33 EPS Q/Q-5.38% Payout63.81% Rel Volume0.82 Prev Close113.86
Sales Surprise0.08% EPS Surprise3.17% Sales Q/Q4.00% EarningsJul 18 BMO Avg Volume6.24M Price116.43
SMA204.13% SMA508.07% SMA2006.73% Trades Volume5,100,486 Change2.26%
Date Action Analyst Rating Change Price Target Change
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Apr-20-23Reiterated Raymond James Outperform $116 → $123
Apr-20-23Reiterated JP Morgan Overweight $118 → $122
Apr-20-23Reiterated Bernstein Outperform $132 → $133
Apr-20-23Reiterated Barclays Overweight $125 → $127
Sep-05-24 04:08PM
02:45PM
09:30AM
09:29AM
09:00AM
09:00AM Loading…
09:00AM
09:00AM
Sep-04-24 09:00AM
08:00AM
Sep-03-24 11:32PM
05:50PM
Aug-30-24 06:45AM
Aug-29-24 03:26PM
Aug-28-24 05:50PM
Aug-27-24 01:13PM
09:00AM Loading…
09:00AM
Aug-25-24 06:30PM
Aug-24-24 03:22PM
Aug-23-24 09:12AM
Aug-22-24 05:50PM
Aug-21-24 01:54PM
09:00AM
08:00AM
Aug-20-24 09:30AM
Aug-17-24 09:10AM
Aug-16-24 08:50PM
Aug-15-24 01:44PM
Aug-14-24 08:00AM
Aug-13-24 07:03PM
07:03PM
02:45PM Loading…
02:45PM
03:32AM
Aug-12-24 08:29PM
Aug-11-24 07:28AM
Aug-09-24 09:00AM
Aug-08-24 09:00AM
Aug-07-24 04:57PM
01:45PM
09:00AM
08:00AM
08:00AM
05:10AM
Aug-06-24 04:26PM
04:23PM
09:00AM
Aug-03-24 06:45AM
Aug-02-24 09:30AM
08:00AM
05:17AM
Jul-31-24 11:08AM
Jul-30-24 10:49AM
09:30AM
08:54AM
08:18AM
Jul-29-24 04:32PM
04:16PM
03:47PM
03:23PM
02:37PM
02:06PM
12:29PM
10:46AM
10:09AM
08:01AM
07:48AM
07:43AM
07:37AM
05:54AM
03:34AM
01:02AM
Jul-26-24 09:36PM
05:27AM
Jul-25-24 12:30PM
07:00AM
Jul-24-24 09:00AM
08:00AM
03:22AM
Jul-20-24 08:45PM
07:00AM
Jul-19-24 12:33PM
03:11AM
Jul-18-24 06:16PM
04:17PM
03:00PM
02:34PM
01:57PM
01:39PM
11:55AM
11:06AM
10:32AM
09:54AM
09:30AM
08:45AM
07:43AM
07:42AM
07:32AM
07:30AM
06:01AM
Jul-13-24 11:00AM
Jul-11-24 10:28AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCCOY JOHN A. JR.VICE PRESIDENTSep 04 '24Sale114.83273,10018,681Sep 04 07:52 PM
Funck, Jr. Robert E.OfficerSep 04 '24Proposed Sale115.0030,0003,450,000Sep 04 04:04 PM
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMay 10 '24Option Exercise47.0010,097474,559221,438May 14 05:35 PM
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMay 10 '24Sale104.5710,0971,055,819211,341May 14 05:35 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMay 07 '24Sale106.2522,8522,428,11961,462May 08 05:00 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50963114,116125,697Mar 04 07:18 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5080194,91862,968Mar 04 07:14 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5067680,10691,260Mar 04 07:09 PM
MCCOY JOHN A. JR.VICE PRESIDENTMar 01 '24Sale118.5047255,93218,760Mar 04 07:05 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5069482,23984,314Mar 04 06:50 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50853101,080184,806Mar 04 06:39 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Option Exercise59.9412,500749,25091,204Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Sale120.0012,5001,500,00078,704Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Option Exercise50.8042,5002,158,95090,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Sale112.5042,5004,781,25065,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Option Exercise44.4015,000666,00080,027Dec 18 05:36 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Sale108.0015,0001,620,00065,027Dec 18 05:36 PM
STARKS DANIEL JDirectorOct 26 '23Sale94.0550,0004,702,5266,725,316Oct 30 04:58 PM